Comparing the antiepileptic effects of atorvastatin, celecoxib, ashwagandha, clove oil, and Sodium valproate on chemo-shock induced seizures in male Wistar albino rats
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20230384Keywords:
Epilepsy, Anti-epileptic drugs, Atorvastatin, Celecoxib, Ashwagandha, Clove oil, Sodium valproateAbstract
Background: Antiepileptic potential of statins, COX inhibitors and other herbal medications are to be evaluated in experimental animals so that the most efficacious can be translated for human use as an adjunct to the commonly used anti-epileptic drugs.
Methods: This experimental animal study grouped 30 male Wistar albino rats into 6 groups with each containing 5 rats of which one group was control, one was the standard drug and the other 4 were treatment groups which received Atorvastatin, Celecoxib, Ashwagandha and Clove oil. These drugs were administered 30 minutes prior to administering Pentylene-tetrazole which induced convulsions and the various seizure parameters were analysed. The blood samples of the animals were also assessed for anti-oxidant activity by measuring superoxide dismutase and catalase levels in the blood.
Results: The onset of seizure was significantly delayed by Ashwagandha (2.55±0.94), similar to the latency shown by the standard drug (2.09±1.21). The duration of convulsions was very significantly reduced in all the 5 drug groups in comparison to the control (p<0.001). The clonic jerk duration was not reduced as effectively as the standard drug. The duration of recovery time amongst the various groups was also significant (p<0.05). The SOD and Catalase levels of no groups showed any possible association between the anti-epileptic efficacy of these drugs and the anti-oxidant enzyme levels.
Conclusions: Ashwagandha has good anti-epileptic efficacy not less than the standard drug when the various drug groups were compared.
References
Wahab A. Difficulties in treatment and management of epilepsy and challenges in new drug development. Pharmaceuticals. 2010;3(7):2090-110.
Elferink JG. Epilepsy and its treatment in the ancient cultures of America. Epilepsia. 1999;40(7):1041-6.
McNamara JO. Pharmacotherapy of the Epilepsies. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw-Hill Education; 2015.
Epilepsy. Available at: https://www.who.int/news-room/fact-sheets/detail/epilepsy. Accessed on 20 November 2021.
Löscher W. Current status and future directions in the pharmacotherapy of epilepsy. Trends Pharmacol Sci. 2002;23(3):113-8.
Löscher W, Brandt C. Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol Rev. 2010;62(4):668-700.
Rojas A, Jiang J, Ganesh T, Yang M-S, Lelutiu N, Gueorguieva P, et al. Cyclooxygenase-2 in epilepsy. Epilepsia. 2014;55(1):17-25.
Dixit AB, Banerjee J, Chandra PS, Tripathi M. Recent advances in epilepsy research in India. Neurol India. 2017;65(1):S83-92.
Kaul SC, Ishida Y, Tamura K, Wada T, Iitsuka T, Garg S, et al. Novel methods to generate active ingredients-enriched ashwagandha leaves and extracts. PLoS One. 2016;11(12):e0166945.
Tsiara S, Elisaf M, Mikhailidis DP. Early vascular benefits of statin therapy. Curr Med Res Opin. 2003;19(6):540-56.
Singh AP, S. RM. Potential anti-seizure activity of atorvastatin in rat models of seizure. Int J Basic Clin Pharmacol. 2022;6(1):35-8.
Khoshnoud MJ, Tanideh N, Namdarian S. Anticonvulsant activity of atorvastatin against seizure induced by pentylenetetrazole and maximal electroshock in mice. Trends Pharm Sci. 2015;1(1):44-7.
Minghetti L, Pocchiari M. Cyclooxygenase-2, prostaglandin E2, and microglial activation in prion diseases. Int Rev Neurobiol. 2007;82:265-75.
Nadeem MN, Maqdoom M. Evaluation of anticonvulsant effect of celecoxib, a selective cyclooxygenase-2 inhibitor in experimentally induced convulsions in albino rats. Int J Basic Clin Pharmacol. 2017;5(4):1466-70.
Raju S, PL B, HN N, Shanbhag A. A study on the anticonvulsant activity of Withania somnifera (Dunal) in albino rats. Natl J Physiol Pharm Pharmacol. 2016;6:1.
Meher S, Das B, Panda P, Bhuyan GC, Meda M. Uses of Withania somnifera (Linn) Dunal (Ashwagandha) in Ayurveda and its Pharmacological Evidences. Res J Pharmacol Pharmacodyn. 2016;8:23.
Pourgholami MH, Kamalinejad M, Javadi M, Majzoob S, Sayyah M. Evaluation of the anticonvulsant activity of the essential oil of Eugenia caryophyllata in male mice. J Ethnopharmacol. 1999;64(2):167-71.
Avanthi E, Kumar L P, Somashekar H. The study of antiepileptic activity of clove oil in chemical induced convulsions in mice. Int J Basic Clin Pharmacol. 2015;956-9.
Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, et al. Oxidative Stress: Harms and Benefits for Human Health. Oxid Med Cell Longev. 2017;2017:8416763.
Kangralkar VA, Patil SD, Bandivadekar RM. Oxidative stress and diabetes: a review. Int J Pharm Appl. 2010;1(1):38-45.
Younus H. Therapeutic potentials of superoxide dismutase. Int J Health Sci (Qassim). 2018;12(3):88-93.
Yasui K, Baba A. Therapeutic potential of superoxide dismutase (SOD) for resolution of inflammation. Inflamm Res Off J Eur Histamine Res Soc. 2006;55(9):359-63.
Deisseroth A, Dounce AL. Catalase: Physical and chemical properties, mechanism of catalysis, and physiological role. Physiol Rev. 1970;50(3):319-75.
von Ossowski I, Hausner G, Loewen PC. Molecular evolutionary analysis based on the amino acid sequence of catalase. J Mol Evol. 1993;37(1):7-6.
Shehta N, Kamel AE, Sobhy E, Ismail MH. Malondialdehyde and superoxide dismutase levels in patients with epilepsy: a case-control study. Egypt J Neurol Psychiatr Neurosurg. 2022;58(1):1-7.
